Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy-Reference-Cited by-同舟云学术

Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy

Published:2014-12-26 Issue:8 Volume:26 Page:1889-1904
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Oltean Sebastian,Qiu Yan,Ferguson Joanne K.,Stevens Megan,Neal Chris,Russell Amy,Kaura Amit,Arkill Kenton P.,Harris Kirstie,Symonds Clare,Lacey Katja,Wijeyaratne Lihini,Gammons Melissa,Wylie Emma,Hulse Richard P.,Alsop Chloe,Cope George,Damodaran Gopinath,Betteridge Kai B.,Ramnath Raina,Satchell Simon C.,Foster Rebecca R.,Ballmer-Hofer Kurt,Donaldson Lucy F.,Barratt Jonathan,Baelde Hans J.,Harper Steven J.,Bates David O.,Salmon Andrew H.J.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference56 articles.

1. Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015

2. Diabetic Retinopathy

3. Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.

4. Mechanisms of Diabetic Complications

5. Kidney complications: Factors that protect the diabetic vasculature

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal effects of noise and air pollution on multiple diseases highlight the dual role of inflammatory factors in ambient exposures;Science of The Total Environment;2024-11

2. Progress of heparanase in septic cardiomyopathy: A review;Medicine;2024-08-16

3. Esm-1 mediates transcriptional polarization associated with diabetic kidney disease;American Journal of Physiology-Renal Physiology;2024-06-01

4. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes;Cardiovascular Diabetology;2024-02-01

5. Low molecular weight fucoidan restores diabetic endothelial glycocalyx by targeting neuraminidase2: A new therapy target in glycocalyx shedding;British Journal of Pharmacology;2024-01-23